If you want to survive in the investment market, your keen sense of smell, quick movements and accurate judgment are indispensable. Good investment projects can be intercepted the day before signing the contract.

Not to mention projects like Science and Technology Biotechnology, which have high certainty and bright prospects, investors only had one thought in their minds after reading the first clinical report of endorphins: I want to grab this project.

Cheng Gang said helplessly: "You have conducted research on Science and Technology Biotechnology, you should understand that Mr. Zheng is a person who is dedicated to research. After the first phase of the clinical trial report came out, Mr. Lei came to Gusu to inspect and propose to have dinner with Mr. Zheng."

"They ate in our company's cafeteria. After dinner, they talked for less than 20 minutes. Mr. Zheng continued to work in the laboratory."

"Mr. Zheng spends more than fourteen hours a day in the laboratory and has no time to go out for dinner."

"The boss is more diligent than the employees below. I feel ashamed of myself. The first thing Mr. Lei said to me after dinner was: Who can succeed if such a person fails?"

"The second sentence is: The most terrifying thing is that people who are talented than you work harder than you."

Stephanie sighed: "You have to believe in Goldman Sachs' research capabilities. These are all written in our investigation report. We want to invest in Science and Technology Biotechnology not only for endorphins."

"More importantly, I want to invest in Zheng Li, a top scientific research genius combined with unparalleled efforts, and he is still so young, Zheng Li can at least support the development of Science and Technology Innovation Biology in the next 30 years."

"I am very willing to come to your company for a meal and have a meal with Mr. Zheng to chat."

Cheng Gang replied: "Sorry, the first person who called over was Idg's young, and Mr. Zheng really doesn't want to see anyone."

idg’s young    guo, a bachelor’s degree in applied chemistry from Shenhai Jiaotong University, received a doctorate in polymer chemical engineering from Massachusetts State University. He is the first outside investor to realize Zheng Li’s value.

At the beginning of the establishment of Science and Technology Biotechnology, young expressed his desire to participate in the first round of venture capital, but at that time, neither Zheng Li nor Lei Jun wanted to increase capital and expand shares.

"But we will hold a sharing session in the future. At that time, we will have new research results to be announced, and we will also talk about the details of the second round of investment."

"The sharing session should have been in these two days."

......

On a sunny afternoon in Gusu in June, many investors gathered in the open conference room of Sci-tech Biotechnology. Sci-tech Biotechnology only sent invitations to top domestic investment institutions.

Before the sharing session started, investors had already had a linguistic confrontation.

"Hongbo, when will China Merchants Bank International invest in biopharmaceutical companies?"

"Science and Technology Biotechnology is probably inconsistent with your investment philosophy of China Merchants Bank International?" said young from idg Capital and Wang Hongbo from China Merchants Bank International during a chat.

In addition to foreign capital such as IDC Capital, Sequoia, Goldman Sachs, and Morgan, venture capital institutions active in China also have venture capital departments established among domestic front-line banks, including agriculture, industrial, construction, transportation and recruitment.

These banks generally set up their own venture capital departments around 2011.

Wang Hongbo chuckled: "That's not what it means. China Merchants Bank once led the investment in Kangtai Biotechnology and helped Kangtai Biotechnology successfully list on the GEM. We have always been committed to investing in excellent innovative enterprises in China and growing together with outstanding enterprises."

Young thought to himself that everyone doesn’t know who, what are you pretending here: “I’m afraid that only Kangtai Biotechnology companies that China Merchants Bank International has invested in over the years?”

"The last time I invested in Kangtai Biologics was in 2015, and then Kangtai Biologics was listed on the GEM in 2017. I'm afraid you and I know very well what the specific purpose of China Merchants Bank International will invest in Kangtai Biologics."

"Science and Technology Biotechnology will not go public so quickly. Can China Merchants Bank International endure loneliness?"

Wang Hongbo sneered: "You don't need to worry about this. We plan to deeply intervene in the venture capital industry in the biopharmaceutical industry from this year. We are very optimistic about related companies that replace biopharmaceuticals with localized replacement."

Leng Knowledge: China Merchants Bank International invested in Kangtai Biologics in 2015 and has never invested in the biopharmaceutical industry since then, but in 2020 and 2021, it invested in five companies in the biopharmaceutical industry in one go.

The reason is very simple. After the 2018 trade war, the state proposed the requirement of domestically replaced foreign equipment in the backend of financial institutions, which is the so-called "de-ioeization", and proposed that domestically produced equipment should account for at least 70% of the backend of financial institutions.

According to the same logic, the biopharmaceutical industry also needs to realize the top-level will of domestic substitute for imports, so pharmaceutical stocks and pharmaceutical-related venture capital have begun to rise.

young: "China Merchants Bank Capital can only help Science and Technology Biotechnology in capital operations, but IG Capital can help Science and Technology Biotechnology in all aspects. Our investment experience in the biopharmaceutical industry is not comparable to China Merchants Bank International."

Before 2020, Idg Capital's investment experience in the biopharmaceutical industry was indeed much richer than China Merchants Bank International. They have been investing in companies in the biopharmaceutical industry since 1996.

Among them, the most popular monster stock, Jiuan Medical, in 2007, was led by Idg Capital.

Also, don’t think that the investment industry is so high-end. When a truly good project appears, they will use the many vulgar methods as long as they are useful.

Wang Hongbo: "If you only look at industry investment experience, then I think there is no need for Science and Technology Biotech to send invitations to bank venture capital."

"Wouldn't it be better to send it to Goldman Sachs, Morgan, Idg directly?"

"Old old, let's relax. Your competitors are not me, your competitors are Goldman Sachs, Morgan and others, and my competitors are Bank of Communications International, China Construction Bank International, Guosheng Investment, and CICC."

"High-quality enterprises like Science and Technology Biotechnology will definitely not introduce all foreign capital."

young    guo replied: "I'm just curious. Logically speaking, China Merchants Bank International will not participate in companies of this nature."

"What you said makes sense, but according to my news, the final decision is in the hands of Director Zheng, and he has never met any representative of an investment institution."

"Now everyone is all on the same starting line."

"When I saw Mr. Zheng's resume, I was sighing that there are really geniuses in this world. In the second round of venture capital, we valued Science and Technology Biotech at least ten times, 5 billion rmb."

"Dr Zheng is only eighteen years old and has a net worth of over 4 billion rmb. When I was eighteen, I was still brushing test tubes in Shenhai."

Wang Hongbo: "People are different, and our understanding of Zheng Li is still based on his being a top scientific research talent."

"But I think he is not only talented in scientific research capabilities, but also in decisiveness and judgment. After posting nature, he directly chose to take a break from school to start a business. He only met Lei Jun and got a venture capital of 50 million."

“Every step of scouting after getting venture capital is just right.”
Chapter completed!